Novartis share price has zoomed 8% and is presently trading at Rs 1,166.0.
Meanwhile, the BSE HEALTHCARE index is at 43,997.4 (down 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.3%) and Abbott India (up 2.0%).
Sanofi India (down 2.9%) and DR. LAL PATHLABS (down 2.8%) are among the top losers today.
Over the last one year, Novartis has moved up from Rs 722.1 to Rs 1,166.0, registering a gain of Rs 443.9 (up 61.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 43,997.4, registering a gain of 58.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 182.8%), SUVEN PHARMACEUTICALS (up 124.2%) and Glenmark Pharma (up 112.9%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 85,700.6 (up 0.6%).
The top gainers among the BSE Sensex today are Maruti Suzuki (up 4.8%) and M&M (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 26,189.9 (up 0.7%). Maruti Suzuki and M&M are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 85,700.6, registering a gain of 19,676.9 points (up 29.8%).
Novartis net profit grew 27.0% YoY to Rs 257 million for the quarter ended June 2024, compared to a profit of Rs 203 million a year ago. Net sales rose 1.9% to Rs 923 million during the period as against Rs 906 million in April-June 2023.
For the year ended March 2024, Novartis reported 17.6% decrease in net profit to Rs 852 million compared to net profit of Rs 1,034 million during FY23. Revenue of the company fell 11.5% to Rs 3,351 million during FY24.
The current Price to earnings ratio of Novartis, based on rolling 12 month earnings, stands at 31.8.
Equitymaster requests your view! Post a comment on "Novartis Gains 8%; BSE HEALTHCARE Index Down 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!